Can you take tirzepatide or semaglutide with psychiatric drugs?
Yes, in most cases. No tirzepatide (Mounjaro, Zepbound) or semaglutide (Wegovy) label we read names an antipsychotic or antidepressant as an interaction. Labels warn that slower stomach emptying can affect oral medicines. Lithium needs the most care, because doctors have reported toxic lithium levels after starting semaglutide or tirzepatide. The US FDA found no link to suicidal thoughts.
Do these medicines change how psychiatric tablets work?
Tirzepatide and semaglutide slow how fast the stomach empties. Their labels warn that tablets taken by mouth may be absorbed differently.124
We searched the US, UK, EU, Australian and Canadian labels. None names an antipsychotic, antidepressant or lithium.12345678910
The EU Mounjaro label says tirzepatide mainly changes the speed of absorption. This gives a lower, later peak, most of all when treatment starts.3 It expects no dose change for most tablets. It advises monitoring medicines with a narrow safe range (a small gap between a working and a harmful level). This matters most at the start and after each dose rise.3 The US Zepbound label says the delay is largest after the first dose.1
The EU Wegovy label found no meaningful slowing at the 2.4 mg dose, probably because the body adjusts.4 The US Wegovy label still advises monitoring the effects of oral medicines.2
Single case reports exist. In one, a man taking the antipsychotic ziprasidone had higher blood levels and worse paranoia on semaglutide. The paranoia eased after the semaglutide dose was lowered.15 One case cannot show that semaglutide caused it.
Why does lithium need extra care?
Doctors have published reports of lithium rising to toxic levels after people started semaglutide or tirzepatide. The NHS says dehydration can change lithium levels.131621
In a 2025 case series, 3 people on a steady lithium dose started semaglutide. In 2, lithium rose to toxic levels even though their kidney function was stable.13 In the third, cutting the lithium dose in advance lessened the rise, though levels stayed higher than expected.13
The authors suggest possible causes: eating and drinking less, vomiting or diarrhoea, kidney changes and slower stomach emptying.13 They advise checking kidney function, fluid levels and lithium before starting, and lithium more often during treatment.13 A 2026 report described lithium toxicity on tirzepatide that needed dialysis (blood cleaning by machine).21 A 2026 review counted six such reports since 2025. It found slower stomach emptying changes absorption speed rather than the total amount.14
The US Zepbound and EU Wegovy labels say nausea, vomiting and diarrhoea can cause dehydration.14 The NHS checks lithium weekly at first, then every 3 to 6 months once stable.16 It lists confusion, drowsiness, shaking and blurred vision among signs of too much lithium.17 For staying hydrated, see how much water to drink.
Can tirzepatide or semaglutide affect your mood?
In January 2026, the US FDA found no increased risk of suicidal thoughts with these medicines. It asked for the warning to be removed.11
The FDA pooled 91 placebo-controlled trials in 107,910 people. It also found no increased risk of anxiety, depression or psychosis.11 The US labels removed the warning in February 2026.12 In 2024, the European Medicines Agency's safety committee reviewed semaglutide and similar medicines, but not tirzepatide. It found the evidence did not support a causal link.12
Labels still differ. Australian and Canadian labels ask doctors to watch for new or worsening depression, suicidal thoughts or unusual mood changes.78910 The Canadian Wegovy label notes its trials left out people with past suicidal behaviour or major depression.10 The FDA asks people to report new or worse mood changes to a health professional.11
Stopping a psychiatric medicine has its own risks. The NHS says not to stop antidepressants or lithium suddenly.1618 Healthdirect Australia warns that stopping antipsychotics suddenly can bring psychosis back.19
What do people on GLP-1 medicines report about psychiatric medicines?
From public patient forums: 31 Reddit threads in r/Zepbound, r/Semaglutide, r/WegovyWeightLoss, r/glp1, r/Mounjaro and r/mounjarouk, posts from October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Matches the label Many say their psychiatric medicines kept working with no noticeable change, often for months. The EU Mounjaro label expects no dose change for most tablets.3
- Not studied Many felt a psychiatric medicine work less well after starting or raising the GLP-1 dose. Labels say absorption of oral medicines may change and advise monitoring.1 A 2026 review found the speed changes rather than the total amount.14
- Not studied Several blamed extended-release forms, though one person found the opposite. We found no study of extended-release psychiatric medicines with tirzepatide or semaglutide.
- The FDA review says otherwise Many linked low mood or emotional flatness to the GLP-1 itself. The FDA's review of 91 trials found no increased risk of depression. It also asks people to report new mood changes.11
Advice people share
- Matches the FDA Many say to tell the psychiatrist before starting and get a quick review if mood changes. The FDA asks people to report new or worse mood changes to a health professional.11 We found no label line on telling a psychiatrist in advance.
- Matches the NHS Several say to have lithium levels checked and stay well hydrated. The NHS says dehydration can affect lithium levels.1316
- Health services say otherwise Several describe stopping, cutting or raising psychiatric doses on their own. The NHS says not to stop lithium or change its dose without your doctor, and not to stop antidepressants suddenly. Healthdirect Australia says not to stop antipsychotics suddenly.161819
In your country
The advice on absorption and lithium is the same everywhere. Australian and Canadian labels still ask doctors to monitor mood, while US, UK and EU labels do not.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: Australia's Mounjaro and Wegovy labels ask doctors to watch for new or worse depression, suicidal thoughts or unusual mood changes. They also ask doctors to weigh benefits and risks in people with suicidal thoughts or past attempts.78
Emergency number: 000
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: The Canadian Zepbound and Wegovy monographs ask doctors to monitor mood and to stop the medicine if suicidal thoughts appear. They say not to use it in people with past suicide attempts or active suicidal thoughts.910
Emergency number: 911
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: The answer above applies.
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: The answer above applies.
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We did not open an Indian label for this page. It relies on the US, UK, EU, Australian and Canadian labels named above, which differ on mood monitoring.
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a Saudi label for this page. It relies on the US, UK, EU, Australian and Canadian labels named above, which differ on mood monitoring.
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a UAE label for this page. It relies on the US, UK, EU, Australian and Canadian labels named above, which differ on mood monitoring.
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: The answer above applies.
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The answer above applies.
Emergency number: 911
Contact your prescriber or a doctor right away if nausea, vomiting or diarrhoea does not go away. This matters most if you take lithium.116 Do the same if you notice new or worse depression, suicidal thoughts or unusual mood changes.11
Read the full picture
Related questions
Sources
- US Zepbound (tirzepatide) prescribing information and Medication Guide, Eli Lilly, revised August 2026.
- US Wegovy (semaglutide) injection and tablets prescribing information, Novo Nordisk, on DailyMed, revised June 2026.
- EU Mounjaro (tirzepatide) product information, European Medicines Agency.
- EU Wegovy (semaglutide) product information, European Medicines Agency.
- UK Mounjaro KwikPen (tirzepatide) SmPC, electronic medicines compendium.
- UK Wegovy 2.4 mg FlexTouch (semaglutide) SmPC, electronic medicines compendium.
- Australian Mounjaro (tirzepatide) Product Information, version A14.0, October 2026.
- Australian Wegovy (semaglutide) Product Information, Novo Nordisk.
- Canadian Zepbound (tirzepatide) Product Monograph, Eli Lilly Canada.
- Canadian Wegovy (semaglutide) Product Monograph, Novo Nordisk Canada.
- FDA requests removal of suicidal behavior and ideation warning from GLP-1 receptor agonist medications, US Food and Drug Administration, Drug Safety Communication, 13 January 2026.
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC), 8-11 April 2024, European Medicines Agency.
- Al-Soleiti M, Leung JG, Mubaydeen T, et al. Lithium toxicity and altered clearance following initiation of semaglutide in patients with bipolar disorder: a case series and literature review. J Clin Psychopharmacol. 2025;45(6):613-618. Abstract read.
- Cotrik E, da Silva AG, Soares JC. Lithium and GLP-1-based therapies in bipolar disorder: an emerging pharmacovigilance signal and monitoring considerations. Int Clin Psychopharmacol. 2026;41(6):365-370. Abstract read.
- Hejdak D, Razzak AN, Sun L, et al. Interaction of semaglutide and ziprasidone in a patient with schizophrenia: a case report. Cureus. 2024;16(4):e59319. Abstract read.
- How and when to take lithium, NHS, reviewed 9 August 2023.
- Side effects of lithium, NHS, reviewed 9 August 2023.
- Stopping or coming off antidepressants, NHS, reviewed 12 June 2025.
- Antipsychotic medicines, Healthdirect Australia, reviewed November 2025.
- Know When to Go, American College of Emergency Physicians.
- Patarroyo-Rodriguez L, Leung J, Philbrick K, Choe J, Singh B. Tirzepatide-associated lithium toxicity necessitating hemodialysis in previously stable bipolar I disorder. J Clin Psychopharmacol. 2026;46(4):488-490. Title and citation read; no abstract published.
Last checked Nov 16, 2026 · Next review due Nov 16, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked between Nov 9 and Nov 16, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write